Top Ten most popular articles on Pharmafile.com this week
September 11, 2020Medical Communications COVID-19, coronavirus, vaccines
The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
FDA approves GlaxoSmithKline’s Trelegy for treating asthma
September 10, 2020Research and Development Ashtma, inhaler
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
AstraZeneca Chief Executive says vaccine is still possible this year
September 10, 2020Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines
Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …
Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine
September 10, 2020Research and Development COVID, Macaques, Monkey, Vaccine
Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …
President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes
September 10, 2020Medical Communications All the President's men, Bob Woodward, Trump, Watergate
President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …
Pharmafile.com’s weekly COVID-19 news round-up
September 10, 2020Business Services
The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the …
Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO
September 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments
Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
Ali Fattaey appointed Chief Executive Officer of MetaboMed
September 9, 2020Research and Development
MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …
Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds
September 9, 2020Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland
The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …
AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness
September 9, 2020Research and Development AstraZeneca, COVID-19, pharma
Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
Gatherings of over six people to be banned in England from Monday
September 9, 2020Research and Development Lockdown, coronavirus
England is set to increase lockdown restrictions across the country after a surge in coronavirus cases. Currently, most outdoor gatherings …
Roche to start new trials of Ocrevus to defend multiple sclerosis franchise
September 9, 2020Research and Development MS, MS drug, Roche
Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
Major vaccine manufacturers sign COVID-19 safety pledge
September 9, 2020Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine
Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19. The companies involved …
FibroGen names appointment for newly created Chief Scientific Officer role
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen
FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Advaxis Chief Financial Officer resigns
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis
Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
September 8, 2020Manufacturing and Production, Sales and Marketing Cheplapharm, Takeda, pharma
Takeda has revealed it has agreed to divest its non-core portfolio of prescription therapies to Cheplapharm in exchange for an …
Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma
September 8, 2020Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma
New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
Mylan reaches agreement with Aspen for their European thrombosis business
September 8, 2020Manufacturing and Production Mylan, aspen
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million. …
Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme
September 8, 2020Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine
Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …
Up to 60,000 in the UK may have suffered from “long COVID” new data suggests
September 8, 2020Manufacturing and Production Vaccine, pandemic, vaccines
60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
